IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate. With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields. Find more detailed information available on our website below.
Looking for a particular IRBM employee's phone or email?
The IRBM annual revenue was $42.3 million in 2026.
Matteo Liguori is the CEO of IRBM.
166 people are employed at IRBM.
IRBM is based in Pomezia, Latium.
The NAICS codes for IRBM are [541711, 541, 54171, 5417, 54].
The SIC codes for IRBM are [28, 80, 283].